Hafizur Rahman1, Iraklis I Pipinos2, Jason M Johanning2, George Casale3, Mark A Williams4, Jonathan R Thompson3, Yohanis O'Neill-Castro3, Sara A Myers5. 1. Department of Biomechanics, University of Nebraska at Omaha, Omaha, Neb; Department of Surgery and Research Service, Veterans' Affairs Medical Center of Nebraska and Western Iowa, Omaha, Neb. Electronic address: hrahman@unomaha.edu. 2. Department of Surgery and Research Service, Veterans' Affairs Medical Center of Nebraska and Western Iowa, Omaha, Neb; Department of Surgery, University of Nebraska Medical Center, Omaha, Neb. 3. Department of Surgery, University of Nebraska Medical Center, Omaha, Neb. 4. Department of Medicine, Creighton University School of Medicine, Omaha, Neb. 5. Department of Biomechanics, University of Nebraska at Omaha, Omaha, Neb; Department of Surgery and Research Service, Veterans' Affairs Medical Center of Nebraska and Western Iowa, Omaha, Neb.
Abstract
OBJECTIVE: Supervised exercise therapy (SET) is a first-line treatment for patients with peripheral artery disease (PAD). The efficacy of SET is most commonly expressed by significant statistical improvement of parameters that do not clarify how each individual patient will benefit from SET. This study examined the minimal clinically important difference (MCID) in walking speed in claudicating patients with PAD after SET. METHODS: A total of 63 patients with PAD-related claudication (Fontaine stage II PAD) participated in a 6-month SET program. Self-selected walking speed was measured before and after SET. Distribution and anchor-based approaches were used to estimate the MCID for small and substantial improvement. The ability to walk one block and the ability to climb one flight of stairs questions were chosen as anchor questions from the Medical Outcomes Study 36-item Short Form questionnaire. Receiver operating characteristics curve analyses were performed to detect the threshold for MCID in walking speed after treatment. RESULTS: The distribution-based method estimated 0.03 m/s as a small improvement and 0.08 m/s as a substantial improvement after SET. Small and substantial improvements according to the anchor question walking one block were 0.05 m/s and 0.15 m/s, respectively. For the climbing one flight of stairs anchor question, 0.10 m/s was a small improvement. Receiver operating characteristics curve analyses identified an increase of 0.04 m/s and 0.03 m/s for improvement based on walking one block and climbing one flight of stairs, respectively. CONCLUSIONS: We report our findings for the MCID for walking speed among claudicating patients receiving SET. Claudicating patients who increase walking speed of 0.03 m/s or greater are more likely to experience a meaningful improvement in walking impairment than those who do not. The MCID reported in this study can serve as a benchmark for clinicians to develop goals and interpret clinically meaningful progress in the care of claudicating patients with PAD.
OBJECTIVE: Supervised exercise therapy (SET) is a first-line treatment for patients with peripheral artery disease (PAD). The efficacy of SET is most commonly expressed by significant statistical improvement of parameters that do not clarify how each individual patient will benefit from SET. This study examined the minimal clinically important difference (MCID) in walking speed in claudicating patients with PAD after SET. METHODS: A total of 63 patients with PAD-related claudication (Fontaine stage II PAD) participated in a 6-month SET program. Self-selected walking speed was measured before and after SET. Distribution and anchor-based approaches were used to estimate the MCID for small and substantial improvement. The ability to walk one block and the ability to climb one flight of stairs questions were chosen as anchor questions from the Medical Outcomes Study 36-item Short Form questionnaire. Receiver operating characteristics curve analyses were performed to detect the threshold for MCID in walking speed after treatment. RESULTS: The distribution-based method estimated 0.03 m/s as a small improvement and 0.08 m/s as a substantial improvement after SET. Small and substantial improvements according to the anchor question walking one block were 0.05 m/s and 0.15 m/s, respectively. For the climbing one flight of stairs anchor question, 0.10 m/s was a small improvement. Receiver operating characteristics curve analyses identified an increase of 0.04 m/s and 0.03 m/s for improvement based on walking one block and climbing one flight of stairs, respectively. CONCLUSIONS: We report our findings for the MCID for walking speed among claudicating patients receiving SET. Claudicating patients who increase walking speed of 0.03 m/s or greater are more likely to experience a meaningful improvement in walking impairment than those who do not. The MCID reported in this study can serve as a benchmark for clinicians to develop goals and interpret clinically meaningful progress in the care of claudicating patients with PAD.
Authors: Laura Z Gras; Saddam F Kanaan; Joan M McDowd; Yvonne M Colgrove; Jeffrey Burns; Patricia S Pohl Journal: J Geriatr Phys Ther Date: 2015 Jan-Mar Impact factor: 3.381
Authors: Julie K Tilson; Katherine J Sullivan; Steven Y Cen; Dorian K Rose; Cherisha H Koradia; Stanley P Azen; Pamela W Duncan Journal: Phys Ther Date: 2009-12-18
Authors: F A Frans; P T Nieuwkerk; R Met; S Bipat; D A Legemate; J A Reekers; M J W Koelemay Journal: Eur J Vasc Endovasc Surg Date: 2013-10-22 Impact factor: 7.069
Authors: Kruti Patel; Tamar S Polonsky; Melina R Kibbe; Jack M Guralnik; Lu Tian; Luigi Ferrucci; Michael H Criqui; Robert Sufit; Christiaan Leeuwenburgh; Dongxue Zhang; Lihui Zhao; Mary M McDermott Journal: J Vasc Surg Date: 2020-05-19 Impact factor: 4.268
Authors: Hafizur Rahman; Cody P Anderson; Iraklis I Pipinos; Jason M Johanning; George P Casale; Jianghu Dong; Holly DeSpiegelaere; Mahdi Hassan; Sara A Myers Journal: J Biomech Date: 2022-02-25 Impact factor: 2.789